Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2017-03-29 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
2016年度前次募集资金使用情况鉴证报告
Audit Report / Information Classification · 95% confidence The document is a detailed audit report titled "2016年度前次募集资金使用情况鉴证报告" (2016 Annual Previous Fundraising Usage Verification Report) for Guangzhou Yangpu Medical Technology Co., Ltd. It includes an auditor's opinion, references to Chinese regulatory requirements (China Securities Regulatory Commission), and detailed financial data on the use of previously raised funds. The document is prepared by a certified accounting firm (Lixin CPA Firm) and contains substantive financial data and audit conclusions about the use of fundraising proceeds. This matches the definition of an Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles related to specific financial matters, excluding full annual reports. The document is not an announcement or a brief summary but a full verification report with detailed financial analysis and auditor's opinion. Therefore, the correct classification is AR with high confidence. FY 2016
2017-03-29 Chinese
截至2016年12月31日止的前次募集资金使用情况报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "前次募集资金使用情况报告" which translates to "Report on the Use of Previous Fundraising Proceeds". It references regulatory requirements from the China Securities Regulatory Commission and details the use of funds raised through share issuance and asset purchase. The content includes specifics on fundraising amounts, usage, investment projects, and economic benefits realized from the invested funds. It is a detailed report on how previously raised capital was utilized, including financial figures and project status. This type of document is an update on capital usage and fundraising activities, which aligns with the category of Capital/Financing Update (CAP). The document is over 5,000 characters and contains substantive financial and operational data related to fundraising and capital use, not merely an announcement or certification. Therefore, the correct classification is CAP with high confidence.
2017-03-29 Chinese
第三届董事会第三十三次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement of resolutions passed at a board meeting of Guangzhou Yangpu Medical Technology Co., Ltd. It includes approvals of the 2016 annual general manager report, board report, annual report, financial statements audited by an accounting firm, profit distribution plan, internal control self-assessment, fundraising usage report, and other governance matters. The document repeatedly states that these reports and detailed contents are available on the official disclosure website and that these resolutions will be submitted to the shareholders' meeting for approval. The document itself does not contain the full annual report or financial statements but is a formal announcement of board meeting decisions related to the annual report and other governance matters. The document length is 4448 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement of board meeting resolutions and references to reports rather than the reports themselves.
2017-03-29 Chinese
独立董事关于第三届董事会第三十三次会议相关事项的事前认可意见
Board/Management Information Classification · 95% confidence The document is a formal opinion from independent directors regarding the pre-approval of matters to be discussed at the 33rd meeting of the third board of directors of Guangzhou Yangpu Medical Technology Co., Ltd. It includes opinions on the reappointment of the 2017 audit firm and anticipated related party transactions for 2017. The document references regulatory guidelines and company governance rules but does not contain financial statements or detailed audit results. It is a governance-related document focused on board-level approvals and opinions rather than a full audit report or annual report. Therefore, it fits best under Board/Management Information (MANG), which covers announcements related to board or senior management matters, including board meeting opinions and approvals.
2017-03-29 Chinese
独立董事2016年度述职报告（姜傥）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2016 Annual Work Report" for Guangzhou Yangpu Medical Technology Co., Ltd. It is a detailed report by an independent director about their duties, attendance, opinions, committee work, investigations, and suggestions during the 2016 fiscal year. The content focuses on governance, oversight, and compliance activities rather than financial statements or audit results. It does not contain financial data or audit opinions but rather a narrative on the director's role and activities. This type of document fits best under Board/Management Information (MANG), as it relates to management and board-level reporting on governance and director duties. The document length is 3539 characters, which is sufficient for a detailed report but not a full annual report or audit report. Therefore, the classification is MANG with high confidence.
2017-03-29 Chinese
独立董事2016年度述职报告（谢石松）
Board/Management Information Classification · 95% confidence The document is a detailed annual report by an independent director of Guangzhou Yangpu Medical Technology Co., Ltd. for the year 2016. It includes descriptions of attendance at board and shareholder meetings, independent opinions on company matters, committee work, on-site investigations, investor protection efforts, training, and suggestions for company improvement. The content is a formal report on the independent director's duties and activities over the fiscal year, consistent with a management or board-related report rather than a full annual report or audit report. It is not a brief announcement or a certification letter, but a substantive report on governance and oversight activities. Therefore, the document fits best under Board/Management Information (MANG). The document length is 3675 characters, which is relatively short but contains detailed narrative and tables about board activities and independent director duties, not just a notice or announcement.
2017-03-29 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.